Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03336216 |
| Title | A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Bristol-Myers Squibb |
| Indications | |
| Therapies |
Cabiralizumab + Gemcitabine + Nab-paclitaxel + Nivolumab Fluorouracil + Irinotecan + Leucovorin Cabiralizumab + Fluorouracil + Irinotecan + Leucovorin + Nivolumab |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA | ESP | DEU | CAN |